Company / Working Capital per Share
Viking Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.73
FY2025
5-year range
$1.85 / $8.79
FY2021-FY2025
Trend
-34.8%
vs FY2024
Sector context
#100 of 210
Health Care
What the data says
At $5.73, Viking Therapeutics, Inc.'s working capital per share ranks #100 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.63 in FY2017 to $8.79 in FY2024.
Based on SEC 10-K filings.
5.73 in FY2025 with a 5-year CAGR of +11.2%.
Improved from $4.45 to $5.73 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +45.6%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#100 of 210 in Health CareTop 48% of 210This company $5.73 Sector average $146.86
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 34.8% year-over-year.
- Ranks #100 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.73 | -34.8% |
| FY2024 | $8.79 | +97.6% |
| FY2023 | $4.45 | +139.9% |
| FY2022 | $1.85 | -32.7% |
| FY2021 | $2.76 | -18.2% |
| FY2020 | $3.37 | -12.7% |
| FY2019 | $3.86 | -53.6% |
| FY2018 | $8.31 | +1211.3% |
| FY2017 | $0.63 | -18.2% |
| FY2016 | $0.77 | -64.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026